Ulland Investment Advisors, LLC Alvotech Transaction History

Ulland Investment Advisors, LLC

  • $125 Million
  • Q4 2025

A detailed history of Ulland Investment Advisors, LLC transactions in Alvotech stock. As of the latest transaction made, Ulland Investment Advisors, LLC holds 72,500 shares of ALVO stock, worth $398,025. This represents 0.3% of its overall portfolio holdings.

Number of Shares
72,500
Previous 11,250 544.44%
Holding current value
$398,025
Previous $92,000 304.35%
% of portfolio
0.3%
Previous 0.07%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 08, 2026
BUY
$4.83 - $8.95 $295,837 - $548,187
61,250 Added 544.44%
72,500 $372,000
Q3 2025

Nov 13, 2025
BUY
$7.82 - $9.81 $87,975 - $110,362
11,250 New
11,250 $92,000

Others Institutions Holding ALVO

# of Institutions
64
Shares Held
15.1M
Call Options Held
0
Put Options Held
0
View Full List

About Alvotech

ALVO Quotes by TradingView
  • Ticker ALVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 248,650,000
  • Market Cap $1.37B
  • Description
  • Alvotech, through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide. It offers biosimilar products in the therapeutic areas of autoimmune, eye, and bone disorders, as well as cancer. The company's lead program is AVT02, a high concentration formulation biosimilar to Humira to treat various inflammatory condi...
More about ALVO
Track This Portfolio

Track Ulland Investment Advisors, LLC Portfolio

Follow Ulland Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ulland Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ulland Investment Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email